Clinical Trial Update: Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update showing safety and immunogenicity data for RVF003, a Rift Valley Fever vaccine candidate sponsored by the University of Oxford, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rift Valley Fever

Drugs mentioned

• RVF003 Rift Valley Fever vaccine

Snippet

Sponsor: University of Oxford | Conditions: Rift Valley Fever | Phase 2 | Status: ACTIVE_NOT_RECRUITING